Nexgen Energy (NXE) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
2 Feb, 2026Executive summary
Advanced permitting for Rook I project, with federal approval in final stages and strong Indigenous and community support.
Rook I positioned to be the world’s largest uranium mine, targeting over CAD 2 billion annual free cash flow at current prices.
Significant progress in procurement, site infrastructure, and engineering, with construction ready to commence upon final approval.
New greenfield discovery at Patterson Corridor East (PCE) shows strong mineralization, indicating major growth potential.
Robust engagement with utilities and financiers, with increasing interest in offtake and project funding.
Financial highlights
Ended Q2 2024 with CAD 570 million in cash and CAD 340 million in uranium inventory.
Raised CAD 346.5 million in H1 2024; full-year 2024 budgeted spend is CAD 161 million.
Q2 cash G&A was CAD 11.03 million, including one-off capital raising costs.
Updated Rook I NPV at $95/lb uranium is CAD 6.3 billion, with a 12-month payback and CapEx of CAD 2.2 billion.
Outlook and guidance
Expecting federal approval response by end of August/early September, with construction to start soon after and production 40 months later.
Anticipates production before the end of the decade, with full financing package likely post-federal approval.
Contracting strategy remains focused on market-related pricing, with volume commitments increasing closer to production.
Latest events from Nexgen Energy
- Major regulatory, financial, and operational milestones position the company for construction and growth.NXE
Q4 20254 Mar 2026 - Board set at 10, all directors elected, auditors reappointed, and all resolutions passed.NXE
AGM 20243 Feb 2026 - Rook I nears approval as cash reserves, drilling success, and utility demand drive growth.NXE
Q1 202523 Jan 2026 - Rook I is construction-ready, with strong cash, robust contracts, and world-class exploration results.NXE
Q2 202523 Jan 2026 - Q3 net income hit $10.3M, cash rose to $537.8M, and permitting and uranium discovery advanced.NXE
Q3 202415 Jan 2026 - Final EIS, first U.S. contracts, and major PCE discovery mark a transformative 2024.NXE
Q4 202423 Dec 2025 - Concurrent offerings will fund Rook I uranium project development amid high risk and negative cash flow.NXE
Registration Filing29 Nov 2025 - Board set at nine, all motions passed, auditors reappointed, and stock plan amended.NXE
AGM 202511 Nov 2025 - Q3 2025 net loss of $129.2M, $953M equity raised, Rook I nears construction.NXE
Q3 20258 Nov 2025